The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction
- DOI
- 10.1002/cpt.1362
- Published
- 2019-03-18
- Container
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.1362,
title = {The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction},
author = {Joseph P. Menetski and Steven C. Hoffmann and Stephanie S. Cush and Tania Nayak Kamphaus and Christopher P. Austin and Paul L. Herrling and John A. Wagner},
year = {2019},
journal = {Clinical Pharmacology \& Therapeutics},
doi = {10.1002/cpt.1362},
url = {https://doi.org/10.1002/cpt.1362}
}RIS
TY - JOUR TI - The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction AU - Joseph P. Menetski AU - Steven C. Hoffmann AU - Stephanie S. Cush AU - Tania Nayak Kamphaus AU - Christopher P. Austin AU - Paul L. Herrling AU - John A. Wagner PY - 2019 JO - Clinical Pharmacology & Therapeutics DO - 10.1002/cpt.1362 UR - https://doi.org/10.1002/cpt.1362 ER -
APA
Menetski, J. P., Hoffmann, S. C., Cush, S. S., Kamphaus, T. N., Austin, C. P., Herrling, P. L., & Wagner, J. A. (2019). The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.1362
Source records
- crossref · retrieved 2026-09-25T15:17:00.638Z